Skip to main content

Table 2 Distribution of events within 7 days of vaccination by type of vaccine

From: Safety and tolerability of Meningococcus B vaccine in patients with chronical medical conditions (CMC)

Events

Number of vaccinated subjects with one dose

Number of vaccinated subjects with two doses

Total

Local Symptoms

 Local swelling/tenderness

40

12

52

 Refusal to move the extremity

28

17

54

Systemic Symptoms

 Persistent, inconsolable crying lasting ≥3 h

37

11

48

 Fever ≥37.5 °C

29

13

42

Severe adverse reactions

 Hypotonia

5

3

8

 Hypo-responsiveness

4

1

5

 Urticaria/angioedema

4

1

5

  1. ^Total events may not equal the sum of individual symptoms reported, as vaccinated subjects were allowed to report multiple symptoms